Note: Ingredients listed on restricted chemical lists
EC/CAS
202-966-0/9016-87-9
Name of the chemical
4,4'-Methylendiphenyldiisocyanat tech. (Polymeres) MDI, pMDI (in Form atembarer Aerosole, A-Fraktion)
Concentration
≥75-≤90 ≥5% ≥5% ≥5% ≥10-≤25
EC/CAS
202-966-0/101-68-8
Name of the chemical
4,4’-Methylenediphenyl diisocyanate
Concentration
≥5% ≥5% ≥5% <10
EC/CAS
227-534-9/5873-54-1
Name of the chemical
2,4’-Methylenediphenyl diisocyanate
Concentration
≥5% ≥5% ≥5% ≤3
EC/CAS
219-799-4/2536-05-2
Name of the chemical
2,2’-Methylenediphenyl diisocyanate
Concentration
≥5% ≥5% ≥5%
General Information
Revision date
2023-03-27
Product name
Jotafloor PU Universal Comp B
Emergency telephone
+353 1 809 3000
Icons in SDS
Company Information
company name
Jotun A/S
e-mail address of the competent person responsible for the Safety Data Sheet
SDSJotun@jotun.no, SDSJotun@jotun.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H332, H334, H335, H351, H373
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Danger.
Hazard statements
H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H332 - Harmful if inhaled. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 - May cause respiratory irritation. H351 - Suspected of causing cancer. H373 - May cause damage to organs through prolonged or repeated exposure.
Precautionary statements
General : Not applicable.
Prevention
P201 - Obtain special instructions before use. P280 - Wear protective gloves, protective clothing, eye protection, face protection, or hearing protection. P284 - Wear respiratory protection. P260 - Do not breathe vapour or spray.
Response
P308 + P313 - IF exposed or concerned: Get medical advice or attention. P304 + P340, P312 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER or doctor if you feel unwell. P342 + P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor. P362 + P364 - Take off contaminated clothing and wash it before reuse. P302 + P352 - IF ON SKIN: Wash with plenty of water. P333 + P313 - If skin irritation or rash occurs: Get medical advice or attention. P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337 + P313 - If eye irritation persists: Get medical advice or attention.
Storage
P403 + P233 - Store in a well-ventilated place. Keep container tightly closed.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
Hazardous Ingredients
Polymethylenepolyphenyl isocyanate 4,4'-methylenediphenyl diisocyanate o-(p-isocyanatobenzyl)phenyl isocyanate 2,2'-methylenediphenyl diisocyanate
Supplemental label elements
EUH204 - Contains isocyanates. May produce an allergic reaction.
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
As from August 24 2023 adequate training is required before industrial or professional use.
Special packaging requirements
Containers to be fitted with child-resistant fastenings : Not applicable.
Tactile warning of danger
Not applicable.
2.3 Other hazards
Product meets the criteria for PBT or vPvB according : This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Acute Tox. 4, H332 Skin Irrit. 2, H315 Eye Irrit. 2, H319 Resp. Sens. 1, H334 Skin Sens. 1, H317 Carc. 2, H351 STOT SE 3, H335 STOT RE 2, H373 SECTION 2: Hazards identification The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
